Please assess the completion status of the following clinical trial:

Trial Title: Disseminating a Waitlist Treatment for Anxiety With Velibra

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Currently on the Anxiety and Stress Clinic waitlist~* At least 18 years old~* Fluent in English~* Have access to a computer or web device~Exclusion Criteria:~* Active suicidal ideation with intent to harm oneself in the past week (e.g., endorses Yes toC-SSRS item 4 or higher).~* A formal diagnosis of Bipolar I disorder without current utilization of stabilizing medications.~* Present or past psychosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Velibra (Type: EXPERIMENTAL): All treatment will be provided via the Velibra website: https://velibra.broca.io/en/registration/voucher. While the Velibra treatment is only six weeks long, participants will have free access to the program for 24 weeks. They can access this website as often as they would like. The Velibra program is self-guided, so participants determine how often they access the material (the program encourages participants to complete one of six sessions per week for six weeks).

Based on this trial design, predict the completion outcome and termination type (if applicable).